These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28213434)

  • 21. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
    Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.
    Schultz LJ; Steketee RW; Macheso A; Kazembe P; Chitsulo L; Wirima JJ
    Am J Trop Med Hyg; 1994 Nov; 51(5):515-22. PubMed ID: 7985742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
    PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
    Nosten F; McGready R
    Malar J; 2015 Jun; 14():248. PubMed ID: 26088554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
    Briand V; Escolano S; Journot V; Massougbodji A; Cot M; Tubert-Bitter P
    Am J Trop Med Hyg; 2015 Aug; 93(2):300-4. PubMed ID: 26055735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
    Ndeserua R; Juma A; Mosha D; Chilongola J
    Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
    Crawley J; Hill J; Yartey J; Robalo M; Serufilira A; Ba-Nguz A; Roman E; Palmer A; Asamoa K; Steketee R
    Lancet Infect Dis; 2007 Feb; 7(2):145-55. PubMed ID: 17251085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
    Steketee RW; Wirima JJ; Slutsker L; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):50-6. PubMed ID: 8702037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular sulfadoxine-pyrimethamine in uncomplicated chloroquine-resistant falciparum malaria during pregnancy.
    Sowunmi A; Akindele JA; Omitowoju GO; Omigbodun AO; Oduola AM; Salako LA
    Trans R Soc Trop Med Hyg; 1993; 87(4):472. PubMed ID: 8249086
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of malaria at the end of pregnancy on infant mortality and morbidity.
    Bardají A; Sigauque B; Sanz S; Maixenchs M; Ordi J; Aponte JJ; Mabunda S; Alonso PL; Menéndez C
    J Infect Dis; 2011 Mar; 203(5):691-9. PubMed ID: 21199881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
    Parise ME; Ayisi JG; Nahlen BL; Schultz LJ; Roberts JM; Misore A; Muga R; Oloo AJ; Steketee RW
    Am J Trop Med Hyg; 1998 Nov; 59(5):813-22. PubMed ID: 9840604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy and malaria: the perfect storm.
    Rogerson SJ; Unger HW
    Curr Opin Infect Dis; 2022 Oct; 35(5):410-416. PubMed ID: 35916532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
    Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C
    PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.